The Spanish Society of Endocrinology and Nutrition (SEEN), in its position statement on the use of enteral nutrition in advanced dementia,1 outlines the key aspects of this condition, the increasing prevalence of the disease, its social and healthcare impact, nutritional treatment, and related ethical considerations. It also addresses scenarios encountered in routine clinical practice.

First, it is important to bear in mind that hydration and artificial nutrition are life-support measures that require medical indication, a clearly defined therapeutic goal, and the patient’s wishes or informed consent from the individual or their legal representatives.1, 2, 3, 4, 5

This document raises a series of frequently asked questions on how to approach these situations and how to address them with patients and their families or representatives. It also reviews current legislation regarding the right to refuse treatment and shared care planning, as well as decision-making algorithms, a decalogue, and practical guidelines.1

Despite the available scientific evidence, there is ongoing controversy today regarding the use of enteral tube feeding in individuals with advanced dementia.6, 7, 8, 9, 10 In light of this, and following the SEEN position statement, the goal was to reach a consensus among all members of the SEEN Nutrition Area (NutriSEEN) to contribute to improving management of this condition.